Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway

Arthritis and Rheumatism

Volumn 64, Issue 5, 2012, Pages 1540-1550

  Matzelle, Melissa M ^a   Gallant, Maxime A ^b   Condon, Keith W ^b   Walsh, Nicole C ^c   Manning, Catherine A ^a   Stein, Gary S ^a   Lian, Jane B ^a   Burr, David B ^b   Gravallese, Ellen M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; COLLAGENASE 3; DICKKOPF 1 PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; TUMOR NECROSIS FACTOR; WNT10B PROTEIN; WNT7B PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BONE EROSION; BONE MINERALIZATION; BONE REMODELING; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; INFLAMMATION; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIUM; WNT SIGNALING PATHWAY;

ACID PHOSPHATASE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE REGENERATION; FOLLISTATIN-RELATED PROTEINS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; JOINTS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84860461357     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33504     Document Type: Article

References (45)

1. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000; 43: 250-8.
2. Pettit AR, Ji H, von Stechow D, Muller R, Goldring SR, Choi Y, et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001; 159: 1689-99.
3. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, et al. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 2002; 110: 1419-27.
4. Walsh NC, Gravallese EM,. Bone remodeling in rheumatic disease: a question of balance. Immunol Rev 2010; 233: 301-12.
5. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, et al. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/ Pebp2α A) is inhibited by tumor necrosis factor-α. J Biol Chem 2002; 277: 2695-701.
6. Nanes MS,. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology. Gene 2003; 321: 1-15.
7. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD,. Interleukin-1 β is a potent inhibitor of bone formation in vitro. J Bone Miner Res 1987; 2: 559-65.
8. Nguyen L, Dewhirst FE, Hauschka PV, Stashenko P,. Interleukin-1 β stimulates bone resorption and inhibits bone formation in vivo. Lymphokine Cytokine Res 1991; 10: 15-21.
9. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156-63.
10. Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFα induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 2009; 24: 1434-49.
11. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005; 280: 33132-40.
12. Krishnan V, Bryant HU, Macdougald OA,. Regulation of bone mass by Wnt signaling. J Clin Invest 2006; 116: 1202-9.
13. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR,. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 1998; 152: 943-51.
14. Zwerina J, Tuerk B, Redlich K, Smolen JS, Schett G,. Imbalance of local bone metabolism in inflammatory arthritis and its reversal upon tumor necrosis factor blockade: direct analysis of bone turnover in murine arthritis. Arthritis Res Ther 2006; 8: R22.
15. Walsh NC, Reinwald S, Manning CA, Condon KW, Iwata K, Burr DB, et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J Bone Miner Res 2009; 24: 1572-85.
16. Rau R, Wassenberg S, Herborn G, Perschel WT, Freitag G,. Identification of radiologic healing phenomena in patients with rheumatoid arthritis. J Rheumatol 2001; 28: 2608-15.
17. Sharp JT, van der Heijde D, Boers M, Boonen A, Bruynesteyn K, Emery P, et al. Repair of erosions in rheumatoid arthritis does occur: results from 2 studies by the OMERACT Subcommittee on Healing of Erosions. J Rheumatol 2003; 30: 1102-7.
18. Sokka T, Hannonen P,. Healing of erosions in rheumatoid arthritis. Ann Rheum Dis 2000; 59: 647-9.
19. Ideguchi H, Ohno S, Hattori H, Senuma A, Ishigatsubo Y,. Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs. Arthritis Res Ther 2006; 8: R76.
20. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999; 10: 451-61.
21. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D,. Organ-specific disease provoked by systemic autoimmunity. Cell 1996; 87: 811-22.
22. Ohmura K, Nguyen LT, Locksley RM, Mathis D, Benoist C,. Interleukin-4 can be a key positive regulator of inflammatory arthritis. Arthritis Rheum 2005; 52: 1866-75.
23. Sankaramanivel S, Jeyapriya R, Hemalatha D, Djody S, Arunakaran J, Srinivasan N,. Effect of chromium on vertebrae, femur and calvaria of adult male rats. Hum Exp Toxicol 2006; 25: 311-8.
24. Lee SK, Goldring SR, Lorenzo JA,. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 1995; 136: 4572-81.
25. Takahashi N, Udagawa N, Tanaka S, Suda T,. Generating murine osteoclasts from bone marrow. Methods Mol Med 2003; 80: 129-44.
26. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987; 2: 595-610.
27. -ÎÎCT method. Methods 2001; 25: 402-8.
28. Ji H, Pettit A, Ohmura K, Ortiz-Lopez A, Duchatelle V, Degott C, et al. Critical roles for interleukin 1 and tumor necrosis factor α in antibody-induced arthritis. J Exp Med 2002; 196: 77-85.
29. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL,. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 1997; 272: 22053-8.
30. Bennett CN, Ouyang H, Ma YL, Zeng Q, Gerin I, Sousa KM, et al. Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation. J Bone Miner Res 2007; 22: 1924-32.
31. Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet 2005; 37: 945-52.
32. Glass DA 2nd, Bialek P, Ahn JD, Starbuck M, Patel MS, Clevers H, et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 2005; 8: 751-64.
33. Holmen SL, Zylstra CR, Mukherjee A, Sigler RE, Faugere MC, Bouxsein ML, et al. Essential role of β-catenin in postnatal bone acquisition. J Biol Chem 2005; 280: 21162-8.
34. Imai K, Morikawa M, D'Armiento J, Matsumoto H, Komiya K, Okada Y,. Differential expression of WNTs and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. Biochem Biophys Res Commun 2006; 345: 1615-20.
35. Ijiri K, Nagayoshi R, Matsushita N, Tsuruga H, Taniguchi N, Gushi A, et al. Differential expression patterns of secreted frizzled related protein genes in synovial cells from patients with arthritis. J Rheumatol 2002; 29: 2266-70.
36. Li CH, Amar S,. Inhibition of SFRP1 reduces severity of periodontitis. J Dent Res 2007; 86: 873-7.
37. Heath DJ, Chantry AD, Buckle CH, Coulton L, Shaughnessy JD Jr, Evans HR, et al. Inhibiting Dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma. J Bone Miner Res 2009; 24: 425-36.
38. Guo X, Day TF, Jiang X, Garrett-Beal L, Topol L, Yang Y,. Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev 2004; 18: 2404-17.
39. Yamagami T, Molotkov A, Zhou CJ,. Canonical Wnt signaling activity during synovial joint development. J Mol Histol 2009; 40: 311-6.
40. Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 2005; 280: 19883-7.
41. Finzel S, Rech J, Schmidt S, Engelke K, Englbrecht M, Stach C, et al. Repair of bone erosions in rheumatoid arthritis treated with tumour necrosis factor inhibitors is based on bone apposition at the base of the erosion. Ann Rheum Dis 2011; 70: 1587-93.
42. Brown AK, Quinn MA, Karim Z, Conaghan PG, Peterfy CG, Hensor E, et al. Presence of significant synovitis in rheumatoid arthritis patients with disease-modifying antirheumatic drug-induced clinical remission: evidence from an imaging study may explain structural progression. Arthritis Rheum 2006; 54: 3761-73.
43. Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum 2008; 58: 2958-67.
44. McQueen FM,. The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management. Ann N Y Acad Sci 2009; 1154: 21-34.
45. Anandarajah A, Thiele R, Monu J, Seo G, Bokhari A, Ritchlin C,. Rheumatoid arthritis patients in clinical remission manifest persistent joint inflammation on histology and imaging [abstract]. Arthritis Rheum 2010; 62 Suppl: S438.